In patients with T2DM, which is associated with lack of insulin responsiveness, activation of PPARγ by the synthetic drugs TZDs enhances insulin sensitivity leading to enhanced glucose uptake and, thus, a reduction in concentration of plasma glucose [27]. The gene discussed is INS; the disease is type 2 diabetes mellitus.